Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
Following publication of the original article [1], it was brought to our attention that the fifth author’s name was incorrectly published. The original article [1] is corrected.
Main Authors: | Ling Qin, Samantha Stanley, Huihua Ding, Ting Zhang, Van Thi Thanh Truong, Teja Celhar, Anna-Marie Fairhurst, Claudia Pedroza, Michelle Petri, Ramesh Saxena, Chandra Mohan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Arthritis Research & Therapy |
Online Access: | http://link.springer.com/article/10.1186/s13075-019-1966-z |
Similar Items
-
Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
by: Ling Qin, et al.
Published: (2019-07-01) -
Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis
by: N. Pattanashetti, et al.
Published: (2017-09-01) -
Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis
by: Min-Hua Tseng, et al.
Published: (2021-02-01) -
POS-120 Renal Thrombotic Microangiopathy in Lupus Nephritis: Risk Factors and Clinical Outcomes
by: T. SYRINE, et al.
Published: (2021-04-01) -
Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
by: Everardo Arias Torres, et al.
Published: (2021-03-01)